NCT04394858 2026-03-18Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting46 enrolled